Brazilian researchers close to biventricular CAD trial milestone
This article was originally published in Clinica
Executive Summary
Brazilian researchers are claiming to be close to launching the country's first human trials of an implantable biventricular cardiac assist device (CAD). According to an announcement posted yesterday on the Hospitalar website, citing the Instituto Dante Pazzanese de Cardiologia, in Sao Paulo, the CAD developed in conjunction with the Fundacao Adib Jatene is about to undergo final trials in calves. Human trials can begin, reportedly, once the device demonstrates 30-day survival in at least three animals.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.